CLDI

0.47755.45%
AF

Antonio Fernandez Santidrian

Head of Technical Operations & Chief Scientific Officer

Dr. Antonio Fernandez Santidrian, Ph.D., Pharm.D. is Chief Scientific Officer at Calidi Biotherapeutics, Inc. since July 2023 and serves as its Head of Technical Operations since January 2025 and served as its Global Head of Research and Development & Senior Vice President since September 2021 until November 2023. He joined Calidi Biotherapeutics, Inc. in 2015 as Associate Director. He is an accomplished scientist with experience in anti-cancer translational research and drug development. He has focused his scientific career on developing superior cancer drugs and on biological drugs to improve human health. He has extensive Supervisory and management experience and excellent skills in biotech business development, communication and collaboration. From March 2008 to September 2015, he led translational studies at The Scripps Research Institute for several small molecule and biologic drugs to treat breast cancer metastasis. He worked closely on the translational cancer studies for the development of ACADRA to treat Chronic lymphocytic leukemia (CLL) at university of Barcelona (Spain). He is the recipient of a fellowship from August Pi I Sunyer Foundation, the Ministry of Science and Education (Spain) and Susan G. Komen Breast cancer foundation. He is co-inventor of Calidi’s Supernova platform. He received degree in Pharmacy by University of Barcelona in 2001 and Ph. D. in biomedicine, specializing in anti-cancer therapies in 2006 from the University of Barcelona in Barcelona, Spain.

公司職務